RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure

Clinical trial NCT07366840 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07366840
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Metastatic Breast Cancer

Start date: 2026-01-16
Primary completion: 2028-01-16
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.